155 related articles for article (PubMed ID: 1247300)
41. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
[TBL] [Abstract][Full Text] [Related]
42. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols.
Steele G; Ellenberg S; Ramming K; O'Connell M; Moertel C; Lessner H; Bruckner H; Horton J; Schein P; Zamcheck N; Novak J; Holyoke ED
Ann Surg; 1982 Aug; 196(2):162-9. PubMed ID: 7046656
[TBL] [Abstract][Full Text] [Related]
43. [Effect of serial CEA determination on diagnosis, therapy and prognosis of recurrent colorectal cancer].
Mentges B
Langenbecks Arch Chir; 1988; 373(4):227-34. PubMed ID: 3210846
[TBL] [Abstract][Full Text] [Related]
44. [Value of carcinoembryonic antigen (CEA) in the diagnosis and postoperative monitoring of patients with colorectal cancer].
Catania G; Basile F; Cardì F; Azzarello G; Mazzarino C; Campo M; Giovinetto A
Minerva Chir; 1981 May; 36(9):569-80. PubMed ID: 6789243
[No Abstract] [Full Text] [Related]
45. Carcinoembryonic antigen: 3 years' experience in a cancer clinic.
Koch M; McPherson TA; Morrish DW
Can Med Assoc J; 1977 Apr; 116(7):769-71. PubMed ID: 849560
[TBL] [Abstract][Full Text] [Related]
46. CEA radioimmunoassay. Clinical applications in colorectal cancer.
Huyghe J
Acta Chir Belg; 1983; 83(2):77-88. PubMed ID: 6858539
[TBL] [Abstract][Full Text] [Related]
47. Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer.
Mayer RJ; Garnick MB; Steele GD; Zamcheck N
Cancer; 1978 Sep; 42(3 Suppl):1428-33. PubMed ID: 709511
[TBL] [Abstract][Full Text] [Related]
48. Is CEA analysis of value in screening for recurrences after surgery for colorectal carcinoma?
Carlsson U; Stewénius J; Ekelund G; Leandoer L; Nosslin B
Dis Colon Rectum; 1983 Jun; 26(6):369-73. PubMed ID: 6133709
[TBL] [Abstract][Full Text] [Related]
49. [Prognostic value of CEA in postoperative monitoring of colorectal cancers].
Cossu F; Fodde M; Ledda P; Pisano G; Rombi GP; Scintu F; Tuveri A
Minerva Med; 1984 Oct; 75(40):2373-80. PubMed ID: 6504398
[TBL] [Abstract][Full Text] [Related]
50. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
[TBL] [Abstract][Full Text] [Related]
51. [Significance of carcinoembryonic antigen in the treatment of colorectal cancers].
Putzki H
Zentralbl Chir; 1986; 111(18):1119-23. PubMed ID: 3788331
[TBL] [Abstract][Full Text] [Related]
52. [Significance of 2d look operations in colorectal cancers].
Pelikán A
Zentralbl Chir; 1986; 111(18):1109-12. PubMed ID: 3788330
[TBL] [Abstract][Full Text] [Related]
53. A retrospective and prospective study of serial CEA determinations in the early detection of recurrent colon cancer.
Martin EW; Cooperman M; King G; Rinker L; Carey LC; Minton JP
Am J Surg; 1979 Feb; 137(2):167-9. PubMed ID: 426170
[TBL] [Abstract][Full Text] [Related]
54. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
[TBL] [Abstract][Full Text] [Related]
55. Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.
Chester KA; Begent RH
Clin Exp Immunol; 1984 Dec; 58(3):685-93. PubMed ID: 6509799
[TBL] [Abstract][Full Text] [Related]
56. Carcinoembryonic antigen (CEA). A prospective clinical trail in patients with gastrointestinal cancer.
Kjaer M; Fischerman K
Scand J Gastroenterol Suppl; 1976; 37():99-106. PubMed ID: 1064149
[TBL] [Abstract][Full Text] [Related]
57. Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma.
Ito K; Hibi K; Ando H; Hidemura K; Yamazaki T; Akiyama S; Nakao A
Jpn J Clin Oncol; 2002 Feb; 32(2):54-8. PubMed ID: 11948229
[TBL] [Abstract][Full Text] [Related]
58. Abdominal exploration for suspected recurrent carcinoma of the colon and rectum based upon elevated carcinoembryonic antigen alone or in combination with other diagnostic methods.
Wilking N; Petrelli NJ; Herrera L; Holyoke ED; Mittelman A
Surg Gynecol Obstet; 1986 May; 162(5):465-8. PubMed ID: 3704903
[TBL] [Abstract][Full Text] [Related]
59. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
60. CEA as a monitor of gastrointestinal malignancy.
Holyoke ED; Chu TM; Murphy GP
Cancer; 1975 Mar; 35(3):830-6. PubMed ID: 1111949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
